Which adds weight loss, diabetes medications to the basic drug list World Health Organization news

The United Nations Agency urges the production of generational drugs at reasonable prices for the drugs of obesity and diabetes in developing countries.

The World Health Organization (WHO) has added a new set of medicines for obesity and diabetes to the basic medicine list, as well as cancer and cystic fibrosis treatments.

The United Nations Agency said in a statement on Friday that cheap public publications of the GLP -1 (GLP -1) is similar to the glucagon should also be available to people in developing countries.

Recommended stories

List of 3 elementsThe end of the list

The menu, which consists of 523 adult drugs and 374 for children, is a drug catalog that is believed to be available in all operating health systems.

“The new versions of the basic drug lists determined a major step towards expanding the scope of access to new drugs with proven clinical benefits and a high possibility of the impact of global public health,” said Yukiko Nakatani, an assistant general manager of health systems, access and data.

The committee added experts the active ingredients in the Mounto Nordisk and Elie Lily to the list, to treat type 2 diabetes in conjunction with cardiovascular disease or chronic kidney disease.

“The day it releases the latest versions of the basic lists of pharmaceuticals and the basic drugs for children.

These lists are among the most important products, and are used in more than 150 countries to form the purchase of the public sector, supply medicines, and health …

World Health Organization (WHO) (WHO) September 5, 2025

Medicines were initially developed for diabetes, and they became very common as medications that lose weight, too, under different commercial names. But those who did not stop adding them to treat obesity alone, as it did in 2023.

The committee said that this decision provided clear instructions that patients benefit from treatments.

The World Health Organization statement added: “The high prices of drugs such as the poultry and Terzopatid limits access to these drugs,” saying that encouraging public drug makers to produce the product will also help when patents begin in medicines next year.

Other additions

According to the World Health Organization, more than 800 million people worldwide lived with diabetes in 2022, while more than a billion people were affected by obesity.

Earlier this year, the organization announced plans to recommend using obesity medications, which are separate from being included in the basic drug list.

The World Health Organization data shows that in 2021, more than 3.7 million people died from the conditions associated with weight gain or obesity – a number that exceeds the common deaths of malaria, tuberculosis and HIV.

The menu also includes the compound treatment for Vertex Pharmaceuticals for cystic fibrosis or Tricaffa or KAFTRIO. Activists have criticized the high price and insecurity for years.

The World Health Organization’s list also includes MERCK, KEYTRUDA, to treat cervical cancers, colon and rectal cancers, and non -summer lung cancer that spread, or spread. The agency also recommended strategies to increase access to this medicine.

The World Health Organization has added fast -acting insulin analogues, which was also created by Novo Nordisk and Elie Lily, among other things, to the Type 1, type 2 processing list and pregnancy.